Free Trial

Vigil Neuroscience (VIGL) Competitors

Vigil Neuroscience logo
$8.05 0.00 (0.00%)
As of 08/5/2025

VIGL vs. NVTS, AUPH, BHVN, SDGR, EWTX, EVO, ABCL, JANX, ARDX, and WVE

Should you be buying Vigil Neuroscience stock or one of its competitors? The main competitors of Vigil Neuroscience include Navitas Semiconductor (NVTS), Aurinia Pharmaceuticals (AUPH), Biohaven (BHVN), Schrodinger (SDGR), Edgewise Therapeutics (EWTX), Evotec (EVO), AbCellera Biologics (ABCL), Janux Therapeutics (JANX), Ardelyx (ARDX), and WAVE Life Sciences (WVE).

Vigil Neuroscience vs. Its Competitors

Navitas Semiconductor (NASDAQ:NVTS) and Vigil Neuroscience (NASDAQ:VIGL) are related small-cap companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, risk, dividends, valuation and earnings.

46.1% of Navitas Semiconductor shares are owned by institutional investors. Comparatively, 83.6% of Vigil Neuroscience shares are owned by institutional investors. 29.9% of Navitas Semiconductor shares are owned by insiders. Comparatively, 18.0% of Vigil Neuroscience shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Vigil Neuroscience has lower revenue, but higher earnings than Navitas Semiconductor. Navitas Semiconductor is trading at a lower price-to-earnings ratio than Vigil Neuroscience, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Navitas Semiconductor$83.30M17.20-$84.60M-$0.65-10.35
Vigil NeuroscienceN/AN/A-$84.26M-$2.05-3.93

Navitas Semiconductor currently has a consensus target price of $5.65, suggesting a potential downside of 15.99%. Vigil Neuroscience has a consensus target price of $10.80, suggesting a potential upside of 34.16%. Given Vigil Neuroscience's higher probable upside, analysts plainly believe Vigil Neuroscience is more favorable than Navitas Semiconductor.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Navitas Semiconductor
1 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.29
Vigil Neuroscience
0 Sell rating(s)
10 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Vigil Neuroscience has a net margin of 0.00% compared to Navitas Semiconductor's net margin of -182.63%. Navitas Semiconductor's return on equity of -18.16% beat Vigil Neuroscience's return on equity.

Company Net Margins Return on Equity Return on Assets
Navitas Semiconductor-182.63% -18.16% -16.26%
Vigil Neuroscience N/A -111.70%-74.67%

Navitas Semiconductor has a beta of 3.02, indicating that its stock price is 202% more volatile than the S&P 500. Comparatively, Vigil Neuroscience has a beta of 3.33, indicating that its stock price is 233% more volatile than the S&P 500.

In the previous week, Navitas Semiconductor had 7 more articles in the media than Vigil Neuroscience. MarketBeat recorded 9 mentions for Navitas Semiconductor and 2 mentions for Vigil Neuroscience. Vigil Neuroscience's average media sentiment score of 1.21 beat Navitas Semiconductor's score of 0.80 indicating that Vigil Neuroscience is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Navitas Semiconductor
2 Very Positive mention(s)
3 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Vigil Neuroscience
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Navitas Semiconductor beats Vigil Neuroscience on 8 of the 15 factors compared between the two stocks.

Get Vigil Neuroscience News Delivered to You Automatically

Sign up to receive the latest news and ratings for VIGL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VIGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VIGL vs. The Competition

MetricVigil NeuroscienceMED IndustryMedical SectorNASDAQ Exchange
Market Cap$383.91M$3.13B$5.71B$9.79B
Dividend YieldN/A2.21%3.77%4.10%
P/E Ratio-3.9320.9230.9125.28
Price / SalesN/A232.70404.2188.50
Price / CashN/A41.5625.2228.45
Price / Book4.609.779.536.01
Net Income-$84.26M-$54.74M$3.26B$265.34M
7 Day PerformanceN/A8.37%4.66%2.89%
1 Month Performance-0.25%7.94%5.35%1.61%
1 Year Performance130.66%18.27%32.14%25.61%

Vigil Neuroscience Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VIGL
Vigil Neuroscience
3.339 of 5 stars
$8.05
flat
$10.80
+34.2%
N/A$383.91MN/A-3.9340Positive News
NVTS
Navitas Semiconductor
2.7998 of 5 stars
$6.60
-0.9%
$5.65
-14.4%
+123.2%$1.27B$68.17M-10.15160Analyst Downgrade
AUPH
Aurinia Pharmaceuticals
2.6383 of 5 stars
$11.43
+0.5%
$12.00
+5.0%
+96.0%$1.50B$235.13M26.58300Positive News
BHVN
Biohaven
3.7867 of 5 stars
$13.42
-8.9%
$58.46
+335.5%
-59.3%$1.37BN/A-1.43239Earnings Report
Analyst Revision
SDGR
Schrodinger
3.1863 of 5 stars
$18.63
-3.0%
$32.75
+75.8%
-1.8%$1.37B$207.54M-7.51790News Coverage
Analyst Downgrade
EWTX
Edgewise Therapeutics
2.2843 of 5 stars
$12.99
+2.4%
$40.64
+212.8%
-23.3%$1.37BN/A-8.3860Gap Up
EVO
Evotec
1.7764 of 5 stars
$3.81
-3.1%
$5.90
+54.9%
+15.3%$1.35B$862.40M0.004,827Analyst Revision
ABCL
AbCellera Biologics
2.278 of 5 stars
$4.50
+5.9%
$8.00
+77.8%
+75.9%$1.34B$28.83M-8.18500Analyst Upgrade
Gap Up
JANX
Janux Therapeutics
2.7129 of 5 stars
$22.67
-0.7%
$91.89
+305.3%
-39.2%$1.34B$9.34M-12.5930
ARDX
Ardelyx
4.3443 of 5 stars
$5.40
+3.6%
$11.50
+113.0%
+2.1%$1.30B$333.61M-23.4890
WVE
WAVE Life Sciences
4.7361 of 5 stars
$8.10
+0.1%
$20.27
+150.2%
+71.8%$1.29B$108.30M-9.00240

Related Companies and Tools


This page (NASDAQ:VIGL) was last updated on 8/18/2025 by MarketBeat.com Staff
From Our Partners